R Herrmann
Overview
Explore the profile of R Herrmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
472
Citations
3904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grasemann C, Herrmann R, Starschinova J, Gertsen M, Palmert M, Grasemann H
Nutr Diabetes
. 2017 Feb;
7(2):e244.
PMID: 28218737
Background/objectives: Alterations in the L-arginine/nitric oxide (NO) metabolism contribute to diseases such as obesity, metabolic syndrome and airway dysfunction. The impact of early-life exposures on the L-arginine/NO metabolism in lung...
2.
Koeberle D, Betticher D, von Moos R, Dietrich D, Brauchli P, Baertschi D, et al.
Ann Oncol
. 2015 Jan;
26(4):709-714.
PMID: 25605741
Background: Chemotherapy plus bevacizumab is a standard option for first-line treatment in metastatic colorectal cancer (mCRC) patients. We assessed whether no continuation is non-inferior to continuation of bevacizumab after completing...
3.
Herrmann R, Stottlemyer R
Environ Monit Assess
. 2013 Nov;
17(1):51-65.
PMID: 24233373
The U.S. National Park Service (NPS) is faced with direct questions about the condition of Park natural resources. The watershed approach to long-term monitoring of natural, and remote areas within...
4.
Westerhausen C, Strobl F, Herrmann R, Bauer A, Schneider S, Reller A, et al.
Biophys J
. 2012 Mar;
102(5):1032-8.
PMID: 22404925
The interaction of nanoparticles (NPs) with lipid membranes is an integral step in the interaction of NPs and living cells. During particle uptake, the membrane has to bend. Due to...
5.
Tampi R, Herrmann R, Barr A, Wright M
Intern Med J
. 2012 Jan;
42(1):111.
PMID: 22276566
No abstract available.
6.
Purtill D, Cooney J, Cannell P, Herrmann R, Trimboli F, Carter T, et al.
Intern Med J
. 2011 Oct;
42(9):1008-13.
PMID: 21981267
Background/aims: Thirty-one umbilical cord blood transplants performed in Western Australia were retrospectively examined in order to document local experience and relevant prognostic factors. Three cord units were from human leucocyte...
7.
Radke M, Behrends T, Forster J, Herrmann R
Anal Chem
. 2011 Jun;
71(23):5362-6.
PMID: 21662732
In the work reported here, a state-of-the-art analytical method for the quantitative analysis of cationic surfactants in environmental matrixes is described. High-performance liquid chromatography on-line coupled via an electrospray interface...
8.
Bernhard J, Dietrich D, Glimelius B, Hess V, Bodoky G, Scheithauer W, et al.
Br J Cancer
. 2010 Sep;
103(9):1318-24.
PMID: 20877359
Background: To investigate the prognostic value of quality of life (QOL) relative to tumour marker carbohydrate antigen (CA) 19-9, and the role of CA 19-9 in estimating palliation in patients...
9.
Rochlitz C, Ruhstaller T, Lerch S, Spirig C, Huober J, Suter T, et al.
Ann Oncol
. 2010 Jul;
22(1):80-85.
PMID: 20595448
Background: pegylated liposomal doxorubicin (PLD) and bevacizumab are active agents in the treatment of metastatic breast cancer (MBC). We carried out a multicenter, single-arm phase II trial to evaluate the...
10.
Hess V, Pratsch S, Potthast S, Lee L, Winterhalder R, Widmer L, et al.
Ann Oncol
. 2010 May;
21(12):2390-2395.
PMID: 20444846
Background: Gemcitabine remains the mainstay of palliative treatment of advanced pancreatic carcinoma (APC). Adding capecitabine or a platinum derivative each significantly prolonged survival in recent meta-analyses. The purpose of this...